◆#merck

2 articles

Markets

Moderna Stock Drops 25% Despite Positive Phase 3 Cancer Vaccine Trial Data

Oct 23, 2026·3m read

Regulation

Merck and Hashgraph Group Unveil Hedera-Powered Product Passport for EU Compliance

Jun 9, 2026·3m read